Rubella Diagnostic Testing Market

Rubella Diagnostic Testing Market Size Survey Report – In a Glance

As per the survey report on global Rubella diagnostic testing market, the market is projected to foresee a CAGR of 5.2% between 2024-2033, and further generate a market size of USD 2.4 billion revenue by the end of 2033. In the year 2024, the market size was valued at USD 1.4 billion revenue.

• The global Rubella diagnostic testing market is projected to grow on account of the government initiatives for Rubella elimination.
• In Japan, the Rubella diagnostic testing market growth can be attributed to the improved healthcare facilities.
• KDMI analyst’s growth analysis foresees decline in disease incidence in the vaccinated population to challenge the market growth.
• North America, having the highest market share in the Rubella diagnostic testing market, is projected to dominate the global market.

Rubella Diagnostic Testing Market Analysis

Rubella, also known as German measles, is a communicable disease caused due to the infection by a virus, scientifically called Rubivirus rubellae, marked by distinctive red rashes, low-grade fever, swollen lymph nodes, and sore throat. Rubella diagnostic testing is crucial for diagnosing current or past infections and identifying the immune condition. In recent times, government initiatives for Rubella elimination are helping the Rubella diagnostic testing market to achieve growth and development globally. It is assumed that there has been a 98% decline in the death rate due to measles in the South-East Asian region by 2020 compared to 2000 and the estimated number of measles cases reduced by 82% in the same period. Moreover, five countries namely Bhutan, DPR Korea, Maldives, Sri Lanka, and Timor-Leste have confirmed measles elimination, and in 2021, Maldives and Sri Lanka have encountered their rubella elimination status. Abbott, Bio Rad Laboratories Inc., BioMérieux SA, are some of the significant parties in the global market for Rubella diagnostic testing.

Analyst’s Observation on Japan Rubella Diagnostic Testing Market Survey

In Japan, the market growth for Rubella diagnostic testing can be attributed to the improved healthcare facilities. Based on various surveys, Japan’s market for diagnostic and therapeutic AI healthcare tools is forecasted to be roughly $114 million by 2027. Furthermore, there will be an increase in Japan’s telemedicine market from USD 243 million in 2020 to USD 404.5 million by 2025. The wearable healthcare equipment (smart watches, etc.) and service systems (online monitoring services for the elderly, etc.) in Japan’s healthcare IT market will make it to 16 billion by 2025. Also, Japan’s health tech segment such as sleep-tech and baby-tech section is expected to flourish to USD 2 billion by 2025. Beckman Coulter Inc., Bio Rad Laboratories Inc., Thermo Fisher Scientific Inc, are some of the significant parties in the market for Rubella diagnostic testing in Japan.

Rubella Diagnostic Testing Market Growth Driver and Challenges

Growth Driver

Recurrence of rubella outbreaks:

The re-emergence of Rubella outbreaks plays a crucial role in expanding the Rubella diagnostic testing market globally. Rubella is an infectious disease for which 20% to 50% of cases are asymptomatic and its transmission can occur in congregate settings such as households, workplaces, universities, jails, or communities. Most recent rubella outbreaks were first identified in the workplace. Approximately 17,865 cases of rubella were detected in 78 countries in 2022, even though a safe and cost-effective vaccine was accessible.

It was also reported that more than 100,000 children born each year were affected with congenital rubella syndrome (CRS), which includes heart defects, blindness, and deafness, causing a threat to pregnant women and their fetuses in particular. Around 345 rubella cases were reported by 17 countries, mostly from Poland, Kyrgyzstan, Tajikistan, Türkiye, and Ukraine In 2023. Moreover, in total 262 cases (76%) were classified as compatible with clinical findings, and 79 (23%) were confirmed by laboratory reports.

Restraint

Decline in disease incidence in the vaccinated population:

In many nations such as the United States, Canada, and many European countries, Rubella incidence has declined drastically with strong Rubella vaccination coverage, blocking the Rubella diagnostic testing market growth. Starting from January 2024, 175 out of 194 countries had implemented rubella vaccines and worldwide reach was predicted to be 69%. It has also been reported that the overall rubella cases dropped 97%, from 670 894 cases in 102 countries in 2000 to 17 865 cases in 78 countries in 2022. The Centers for Disease Control and Prevention (CDC) stated that the total count of rubella infections in the United States has reduced substantially since the rubella vaccination was introduced in 2023 and less than 10 cases were reported annually.

Rubella Diagnostic Testing Market Segmentation

Our experts at KD Market Insights have segmented the global Rubella diagnostic testing market research report as:

Rubella Diagnostic Testing Market Regional Synopsis

The North America Rubella diagnostic testing market is majorly driven by crucial market contributors, major government initiatives, and technical innovations for immediate and timely diagnosis of the condition. The Centers for Disease Control and Prevention (CDC) declared in January 2021 that Rubella is not endemic anymore in the United States and executing a high-quality surveillance system is important for the eradication of Rubella in the North American region. In addition, unveiling cutting-edge technologies accelerated the region’s explored industry’s growth. For example, the Journal of Virology Methods published an article in May 2022 in which it stated that the COVID-19 pandemic has interrupted rubella vaccination services all over the world, bringing about an amplified immunity gap, and RV genotype surveillance is an indispensable part of tracking progress toward rubella elimination and eradication goals.

Asia Pacific region is foreseen to expand at the fastest CAGR growth of the rubella diagnostic testing market worldwide during the predicted time frame, in which India is the leading nation.  The market is governed by the escalating population, improved healthcare facilities, and surging demand for lower healthcare costs. Moreover, the Indian government has formulated a treatment plan to extend the diagnostic facilities. The Ministry of Health & Family Welfare (MoHFW), the government of India, launched the Pradhan Mantri Surakshit Matritva Abhiyan campaign as a feature of the reproductive maternal neonatal child and adolescent health strategy to improve the quality and coverage of ANC (Ante-Natal Care) with diagnostics and counseling services.

As per our analysts at KD Market Insights, the following five players lead the North America Rubella diagnostic testing market growth:

• Abbott
• Bio Rad Laboratories Inc.
• bioMérieux SA
• Siemens Healthcare GmbH
• Thermo Fisher Scientific Inc.

Rubella Diagnostic Testing Market Competitive Landscape

Some of the key players who top the global Rubella diagnostic testing market share:

• Beckman Coulter Inc.
• Biokit SA
• BioMérieux SA
• Hoffmann-La Roche Ltd
• Ortho Clinical Diagnostics
• Siemens Healthcare GmbH
• Bio Rad Laboratories Inc.
• Thermo Fisher Scientific Inc
• ZEUS Scientific Inc
• GlaxoSmithKline plc.

1. Executive Summary
   1. Market Overview
   2. Key Findings
   3. Market Trends
   4. Market Outlook
2. Introduction
   1. Scope of the Report
   2. Research Methodology
   3. Definitions and Assumptions
   4. Acronyms and Abbreviations
3. Market Dynamics
   1. Drivers
   2. Restraints
   3. Opportunities
   4. Challenges
4. Global Rubella Diagnostic Testing Market
   1. Market Overview
   2. Market Size and Forecast
   3. Market Segmentation
      1. By Testing technique
      2. By Application
      3. By Age group
      4. By Region
5. Market Segmentation by Testing technique
   1. 1. Latex agglutination
      2. Enzyme-immunoassay (EIA)
      3. Radioimmunoassay (RIA)
      4. Fluorescent immunoassay (FIA)
      5. Others
6. Market Segmentation by Application
   1. 1. Hospitals
      2. Laboratories
      3. Others
7. Market Segmentation by Age group
   1. 1. Neonates
      2. Teenagers
      3. Adults
8. Regional Analysis
   1. North America
      1. United States
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Testing technique, Application, and Age group
      2. Canada
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Testing technique, Application, and Age group
      3. Mexico
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Testing technique, Application, and Age group
   2. Europe
      1. United Kingdom
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Testing technique, Application, and Age group
      2. Germany
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Testing technique, Application, and Age group
      3. France
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Testing technique, Application, and Age group
      4. Italy
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Testing technique, Application, and Age group
      5. Spain
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Testing technique, Application, and Age group
      6. Rest of Europe
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Testing technique, Application, and Age group
   3. Asia Pacific
      1. China
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Testing technique, Application, and Age group
      2. Japan
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Testing technique, Application, and Age group
      3. India
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Testing technique, Application, and Age group
      4. Australia
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Testing technique, Application, and Age group
         4. South Korea
         5. Market Size and Forecast
         6. Key Trends and Developments
         7. Market Analysis by Testing technique, Application, and Age group
      5. Rest of Asia Pacific
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Testing technique, Application, and Age group
   4. Latin America
      1. Brazil
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Testing technique, Application, and Age group
      2. Argentina
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Testing technique, Application, and Age group
      3. Colombia
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Testing technique, Application, and Age group
      4. Rest of Latin America
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Testing technique, Application, and Age group
   5. Middle East & Africa
      1. South Africa
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Testing technique, Application, and Age group
      2. Saudi Arabia
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Testing technique, Application, and Age group
      3. UAE
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Testing technique, Application, and Age group
      4. Rest of Middle East & Africa
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Testing technique, Application, and Age group
9. Competitive Landscape
   1. Market Share Analysis
   2. Company Profiles
   3. Medtronic (Ireland)
   4. IBM
   5. Apple Inc.
   6. Siemens Medical Solutions
   7. Pepperl+Fuchs
   8. Cisco
   9. GE Healthcare
10. Strategic Recommendations
11. Appendix
    1. List of Tables
    2. List of Figures
12. References